252 related articles for article (PubMed ID: 33766920)
1. Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome.
Kojima Y; Uzawa A; Ozawa Y; Yasuda M; Onishi Y; Akamine H; Kawaguchi N; Himuro K; Noto YI; Mizuno T; Kuwabara S
J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):963-968. PubMed ID: 33766920
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting outcome in ocular myasthenia gravis.
Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
[TBL] [Abstract][Full Text] [Related]
3. Effect of Buzhong Yiqi decoction on anti-acetylcholine receptor antibody and clinical status in juvenile ocular myasthenia gravis.
Li J; Qi G; Liu Y
Medicine (Baltimore); 2021 Nov; 100(44):e27688. PubMed ID: 34871253
[TBL] [Abstract][Full Text] [Related]
4. Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis.
Robeson KR; Kumar A; Keung B; DiCapua DB; Grodinsky E; Patwa HS; Stathopoulos PA; Goldstein JM; O'Connor KC; Nowak RJ
JAMA Neurol; 2017 Jan; 74(1):60-66. PubMed ID: 27893014
[TBL] [Abstract][Full Text] [Related]
5. No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.
Wang L; Wang S; Yang H; Han J; Zhao X; Han S; Zhang Y; Lv J; Zhang J; Li M; Ji Y; Zhou S; He X; Fang H; Yang J; Zhang Y; Zhang Q; Gao P; Gao F
Brain Behav; 2021 Jul; 11(7):e02203. PubMed ID: 34075720
[TBL] [Abstract][Full Text] [Related]
6. Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison.
van Steen C; Celico L; Spaepen E; Hagenacker T; Meuth SG; Ruck T; Smith AG; Bodicoat DH; de Francesco M; Iannazzo S
Adv Ther; 2024 Jun; 41(6):2486-2499. PubMed ID: 38642198
[TBL] [Abstract][Full Text] [Related]
7. Analysis of immunoglobulin secretion by lymph organs with myasthenia gravis.
Yoshikawa H; Satoh K; Yasukawa Y; Yamada M
Acta Neurol Scand; 2001 Jan; 103(1):53-8. PubMed ID: 11153889
[TBL] [Abstract][Full Text] [Related]
8. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
9. Response to treatment of myasthenia gravis according to clinical subtype.
Akaishi T; Suzuki Y; Imai T; Tsuda E; Minami N; Nagane Y; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Murai H; Aoki M; Utsugisawa K
BMC Neurol; 2016 Nov; 16(1):225. PubMed ID: 27855632
[TBL] [Abstract][Full Text] [Related]
10. The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis.
Marcuse F; Brandts L; Moens D; Damoiseaux J; Hochstenbag M; Hoeijmakers JGJ; Maessen JG; De Baets M
Eur J Neurol; 2022 Apr; 29(4):1187-1197. PubMed ID: 34967067
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
[TBL] [Abstract][Full Text] [Related]
12. Antibody to acetylcholine receptor in canine and human myasthenia gravis: differential cross-reactivity with human and rabbit receptor.
Dau PC; Yano CS; Ettinger SJ
Neurology; 1979 Jul; 29(7):1065-8. PubMed ID: 572937
[TBL] [Abstract][Full Text] [Related]
13. Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?
Sanders DB; Burns TM; Cutter GR; Massey JM; Juel VC; Hobson-Webb L;
Muscle Nerve; 2014 Apr; 49(4):483-6. PubMed ID: 23835683
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
15. Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.
De Rosa A; Fornili M; Maestri Tassoni M; Guida M; Baglietto L; Petrucci L; Chella A; Melfi F; Lucchi M; Ricciardi R
Thorac Cancer; 2021 Jan; 12(1):106-113. PubMed ID: 33142021
[TBL] [Abstract][Full Text] [Related]
16. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antibody titer to human and rat acetylcholine receptor in myasthenia gravis.
Hayashi M; Takaoka T; Manabe K; Yoshinaga J; Kida K
Brain Dev; 1995; 17(1):38-41. PubMed ID: 7762761
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine receptor autoantibody secretion by thymocytes: relationship to myasthenia gravis.
Yoshikawa H; Lennon VA
Neurology; 1997 Aug; 49(2):562-7. PubMed ID: 9270597
[TBL] [Abstract][Full Text] [Related]
19. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
[No Abstract] [Full Text] [Related]
20. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.
Aurangzeb S; Tariq M; Irshad M; Badshah M; Khan RS
J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
